US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 0.951
  • +0.056+6.26%
Close Oct 4 16:00 ET
  • 0.928
  • -0.023-2.43%
Post 16:09 ET
243.21MMarket Cap-2641P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q2
Stock NameRevenueRatio
Development revenue128.23M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United Kingdom (U.K.)60.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept CAR-T Therapy
CAR-T Therapy
Intraday+0.35%